Email this article 
Immunobiological medicines in treatment of bronchial asthma: experience and prospects of application
- Authors: Ilyina NI1, Kurbacheva OM1, Sizyakina LP2, Ukhanova OP3, Shogenova MS4, Brisin VY.5
-
Affiliations:
- Institute of Immunology
- Rostov State Medical university of the Russian Ministry of Health
- Institute of Postdegree Education of the Stavropol State Medical University
- Center of Allergology of Public Health Ministry of KBR
- Children's Regional Clinical Hospital of Krasnodar Krai
- Issue: Vol 12, No 5 (2015)
- Pages: 90-93
- Section: Articles
- URL: https://rusalljournal.ru/raj/article/view/462
- DOI: https://doi.org/10.36691/RJA462
- ID: 462
Cite item
Open Access
Access granted
Abstract
Full Text
About the authors
N I Ilyina
Institute of Immunology
O M Kurbacheva
Institute of Immunology
L P Sizyakina
Rostov State Medical university of the Russian Ministry of Health
O P Ukhanova
Institute of Postdegree Education of the Stavropol State Medical University
M S Shogenova
Center of Allergology of Public Health Ministry of KBR
V Yu Brisin
Children's Regional Clinical Hospital of Krasnodar Krai
References
- Bateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? The Gaining Op timal Asthma Control study. Am. J. Respir. Crit. Care Med. 2004, v. 170, р. 836-844.
- Partridge M.R., van der Molen T., Myrseth S.E., Busse W.W. Attitudes and actions ofasthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm. Med. 2006, v. 6, р. 13.
- Novelli F., Latorre M., Vergura L. et al. Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy. Pulmonary Pharmacology & Therapeutics. 2015, v. 31, р. 123-129.
- Roth M., Zhong J., Zumkeller S. et al. The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling. PLoS One. 2013, v. 8, e56015.
- Burrows B., Martinez F.D., Halonen M. et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 1989, v. 320, р. 271-277.
- Zureik M., Neukirch C., Leynaert B. et al. Sensitization to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ. 2002, v. 325, р. 411.
- Mouthuy J., Detry B., Sohy C. et al. Presence in sputum of functional dust mite-specific IgE antibodies in intrinsic asthma. Am. J. Respir. Crit. Care Med. 2011, v. 184, р. 206-214.
- Busse W.W., Morgan W.J., Gergen P.J. et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 2011, v. 364, р. 1005-1015.
- James L., Wenzel S. Clinical relevance of airway remodeling in airway diseases. Eur. Respir. J. 2007, v. 30, р. 134-155.
- Wenzel S.E., Schwartz L.B., Langmack E.L. et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 1999, v. 160, р. 1001-1008.
- Rabe K.F., Calhoun W.J., Smith N., Jimenez P. Can anti-IgE therapy prevent airway remodeling in allergic asthma? Allergy. 2011, v. 66, р. 1142-1151.
- Hoshino M., Ohtawa J. Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma. Respiration. 2012, v. 83, р. 520-528.
- Roth M., Zhong J., Zumkeller S. et al. The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling. PLoS One. 2013, v. 8, e56015.
- Nopp A., Johansson S.G.O., Adedoyin J. After 6 years with Xolair; a 3-year withdrawal follow-up. Allergy. 2010, v. 65, р. 56-60.
- Wang C., Zhang L. Specific immunotherapy for allergic rhinitis in children. Curr. Opin. Otolaryngol. Head. Neck. Surg. 2014, v. 22, р. 487-494.
Supplementary files
